TransCode Therapeutics, Inc.
RNAZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,836 | $7 | $12 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,915 | $1 | $1 | $1 |
| Total Curr. Assets | $4,751 | $8 | $13 | $7 |
| Property Plant & Equip (Net) | $20 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $456 | $0 | $0 | $0 |
| Total NC Assets | $476 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,227 | $8 | $13 | $7 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $2 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,968 | $0 | $0 | $0 |
| Total Curr. Liab. | $2,968 | $2 | $3 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $833 | $1 | $0 | $7 |
| Total NC Liab. | $833 | $1 | $0 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,801 | $2 | $3 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$84,420 | -$80 | -$75 | -$63 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $85,846 | $86 | $86 | $61 |
| Total Equity | $1,426 | $6 | $10 | -$2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,227 | $8 | $13 | $7 |
| Net Debt | -$2,836 | -$7 | -$12 | -$6 |